Fine-Tuning the Activation Mode of an 1,3-Indandione-Based Ruthenium(II)-Cymene Half-Sandwich Complex by Variation of Its Leaving Group

Stephan Mokesch, Daniela Schwarz, Michaela Hejl, Matthias H. M. Klose, Alexander Roller, Michael A. Jakupec, Wolfgang Kandioller (Corresponding author), Bernhard K. Keppler

Publications: Contribution to journalArticlePeer Reviewed

Original languageEnglish
Article number2373
Number of pages15
JournalMolecules
Volume24
Issue number13
DOIs
Publication statusPublished - 1 Jul 2019

Austrian Fields of Science 2012

  • 104003 Inorganic chemistry
  • 106023 Molecular biology

Keywords

  • half-sandwich complexes
  • ruthenium(II)-arene complexes
  • leaving group variation
  • anticancer drugs
  • OSMIUM(II)-ARENE COMPLEXES
  • RUTHENIUM
  • CYTOTOXICITY
  • LIGAND
  • DRUG
  • MECHANISM
  • THERAPY
  • PH
  • Ruthenium(II)-arene complexes
  • Anticancer drugs
  • Half-sandwich complexes
  • Leaving group variation

Fingerprint

Dive into the research topics of 'Fine-Tuning the Activation Mode of an 1,3-Indandione-Based Ruthenium(II)-Cymene Half-Sandwich Complex by Variation of Its Leaving Group'. Together they form a unique fingerprint.

Cite this